Beihai Gofar Chuanshan Biological Co (SHSE:600538) Cyclically Adjusted Revenue per Share: ¥0.82 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600538 Beihai Gofar Chuanshan Biological Co Ltd SHSE:600538
55 GF Score
Price ¥5.32
GF Value ¥4.09
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Beihai Gofar Chuanshan Biological Co Cyclically Adjusted Revenue per Share?

Beihai Gofar Chuanshan Biological Co SHSE:600538 +6.83% 55 Cyclically Adjusted Revenue per Share is ¥0.82 as of Mar. 2026. GuruFocus rates SHSE:600538 with a GF Score™ of 55/100 and a GF Value™ of ¥4.09 (Modestly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Beihai Gofar Chuanshan Biological Co's adjusted revenue per share for the three months ended in Mar. 2026 was ¥0.109. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥0.82 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Beihai Gofar Chuanshan Biological Co's average Cyclically Adjusted Revenue Growth Rate was -5.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -8.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -10.00% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was -7.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Beihai Gofar Chuanshan Biological Co was 5.00% per year. The lowest was -11.40% per year. And the median was -6.30% per year.

As of today (2026-08-07), Beihai Gofar Chuanshan Biological Co's current stock price is ¥5.32. Beihai Gofar Chuanshan Biological Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was ¥0.82. Beihai Gofar Chuanshan Biological Co's Cyclically Adjusted PS Ratio of today is 6.49.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Beihai Gofar Chuanshan Biological Co was 8.87. The lowest was 2.20. And the median was 4.44.


Beihai Gofar Chuanshan Biological Co  (SHSE:600538) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Beihai Gofar Chuanshan Biological Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=5.32/0.82
=6.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Beihai Gofar Chuanshan Biological Co was 8.87. The lowest was 2.20. And the median was 4.44.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Beihai Gofar Chuanshan Biological Co Cyclically Adjusted Revenue per Share Related Terms


Beihai Gofar Chuanshan Biological Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Beihai Gofar Chuanshan Biological Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beihai Gofar Chuanshan Biological Co Cyclically Adjusted Revenue per Share Chart

Beihai Gofar Chuanshan Biological Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.24 1.09 0.96 0.88 0.83

Beihai Gofar Chuanshan Biological Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 0.85 0.84 0.83 0.82

SHSE:600538 vs CTVA, CF, MOS: Cyclically Adjusted Revenue per Share Comparison

For the Agricultural Inputs subindustry, Beihai Gofar Chuanshan Biological Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beihai Gofar Chuanshan Biological Co Cyclically Adjusted PS Ratio vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Beihai Gofar Chuanshan Biological Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Beihai Gofar Chuanshan Biological Co's Cyclically Adjusted PS Ratio falls into.


SHSE:600538
55GF Score
Beihai Gofar Chuanshan Biological Co Ltd SHSE:600538
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beihai Gofar Chuanshan Biological Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Beihai Gofar Chuanshan Biological Co's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.109/116.3033*116.3033
=0.109

Current CPI (Mar. 2026) = 116.3033.

Beihai Gofar Chuanshan Biological Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.315 101.400 0.361
201609 0.262 102.400 0.298
201612 0.378 102.600 0.428
201703 0.344 103.200 0.388
201706 0.144 103.100 0.162
201709 0.256 104.100 0.286
201712 0.341 104.500 0.380
201803 0.120 105.300 0.133
201806 0.079 104.900 0.088
201809 0.184 106.600 0.201
201812 0.143 106.500 0.156
201903 0.119 107.700 0.129
201906 0.117 107.700 0.126
201909 0.154 109.800 0.163
201912 0.134 111.200 0.140
202003 0.114 112.300 0.118
202006 0.154 110.400 0.162
202009 0.128 111.700 0.133
202012 0.270 111.500 0.282
202103 0.222 112.662 0.229
202106 0.193 111.769 0.201
202109 0.147 112.215 0.152
202112 0.229 113.108 0.235
202203 0.163 114.335 0.166
202206 0.226 114.558 0.229
202209 0.155 115.339 0.156
202212 0.348 115.116 0.352
202303 0.384 115.116 0.388
202306 0.130 114.558 0.132
202309 0.149 115.339 0.150
202312 0.177 114.781 0.179
202403 0.142 115.227 0.143
202406 0.196 114.781 0.199
202409 0.176 115.785 0.177
202412 0.148 114.893 0.150
202503 0.250 115.116 0.253
202506 0.088 114.907 0.089
202509 0.177 115.471 0.178
202512 0.217 115.832 0.218
202603 0.109 116.303 0.109

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ¥0.82 mean?
Beihai Gofar Chuanshan Biological Co (SHSE:600538) has a Cyclically Adjusted Revenue per Share of ¥0.82 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Beihai Gofar Chuanshan Biological Co and its competitors.
Is Beihai Gofar Chuanshan Biological Co's Cyclically Adjusted Revenue per Share too high?
Beihai Gofar Chuanshan Biological Co's current Cyclically Adjusted Revenue per Share is ¥0.82. Overall, Beihai Gofar Chuanshan Biological Co has a GF Score™ of 55/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Beihai Gofar Chuanshan Biological Co's Cyclically Adjusted Revenue per Share compare to CTVA and CF?
Beihai Gofar Chuanshan Biological Co's Cyclically Adjusted Revenue per Share of ¥0.82 can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for an Agriculture company?
A good Cyclically Adjusted Revenue per Share depends on the Agriculture industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Beihai Gofar Chuanshan Biological Co and its competitors. Beihai Gofar Chuanshan Biological Co's current Cyclically Adjusted Revenue per Share is ¥0.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beihai Gofar Chuanshan Biological Co stock overvalued right now?
Based on GuruFocus' analysis, Beihai Gofar Chuanshan Biological Co (SHSE:600538) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥4.09, compared to a current price of ¥5.32 — trading 30.1% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is ¥0.82. Beihai Gofar Chuanshan Biological Co's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Beihai Gofar Chuanshan Biological Co (SHSE:600538), the current Cyclically Adjusted Revenue per Share is ¥0.82 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beihai Gofar Chuanshan Biological Co (SHSE:600538) Overvalued in 2026?

Based on GuruFocus' analysis, Beihai Gofar Chuanshan Biological Co stock appears to be overvalued. The current stock price of ¥5.32 is trading 30.1% above its estimated GF Value™ of ¥4.09. GuruFocus considers Beihai Gofar Chuanshan Biological Co to be Modestly Overvalued.

Key valuation signals for SHSE:600538:

  • Cyclically Adjusted Revenue per Share: ¥0.82
  • GF Value™: ¥4.09 vs. price of ¥5.32 (30.1% above fair value)
  • GF Score™: 55/100 with 4 warning signs

No single metric tells the full story. See the SHSE:600538 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Beihai Gofar Chuanshan Biological Co Business Description

Address No. 3, Beibuwan Middle Road, Guangxi Zhuang Autonomous Region, Beihai, Guangxi, CHN, 536000
Beihai Gofar Chuanshan Biological Co Ltd main business include pharmaceutical manufacturing and pharmaceutical distribution industry, judicial IVD (in vitro diagnostic) technology services, molecular medical imaging centers and tumor radiotherapy centers and tumor telemedicine technology services, etc.
55GF Score

Get the complete analysis for SHSE:600538

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.32
Price
¥4.09
GF Value